Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bone Biologics Corp. (BBLG)
NASDAQ:BBLG
Bone Biologics (BBLG) Stock Price & Analysis
23 Followers
BBLG Stock Chart & Stats
Day’s Range$1.56 - $1.77
52-Week Range― - ―
Previous Close$1.61
Volume42.83K
Average Volume (3M)N/A
Market Cap
$1.42M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Bone Biologics News
BBLG FAQ
What was Bone Biologics Corp.’s price range in the past 12 months?
Currently, no data Available
What is Bone Biologics Corp.’s market cap?
Currently, no data Available
When is Bone Biologics Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bone Biologics Corp.’s earnings last quarter?
Currently, no data Available
Is Bone Biologics Corp. overvalued?
According to Wall Street analysts Bone Biologics Corp.’s price is currently Overvalued.
Does Bone Biologics Corp. pay dividends?
Bone Biologics Corp. does not currently pay dividends.
What is Bone Biologics Corp.’s EPS estimate?
Bone Biologics Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bone Biologics Corp. have?
Currently, no data Available
What happened to Bone Biologics Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bone Biologics Corp.?
Currently, no hedge funds are holding shares in BBLG
---
Bone Biologics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-97.21%
12-Months-Change
Fundamentals
Return on Equity
-202.15%
Trailing 12-Months
Asset Growth
-56.00%
Trailing 12-Months
Company Description
Bone Biologics Corp.
Bone Biologics Corp. operates as a medical device company, which engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. Its platform technology has application in delivering improved outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA.
---
BBLG Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering BBLG
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-95.80%
initiated a buy rating 11 months ago
Copying Elemer Piros's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -95.80% per trade.
---